Nuveen
TLSI icon

Nuveen’s TriSalus Life Sciences TLSI Stock Holding History

Nuveen’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$291K Buy
63,898
+27,348
+75% +$109K ﹤0.01% 3513
2026
Q1 		$146K Hold
36,550
– – ﹤0.01% 3149
2025
Q4 		$255K Buy
36,550
+15,956
+77% +$89.3K ﹤0.01% 3087
2025
Q3 		$95.8K Hold
20,594
– – ﹤0.01% 3225
2025
Q2 		$112K Buy
+20,594
New +$110K ﹤0.01% 3242

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Nuveen's TLSI Position: Q2 2026 in Review

Nuveen increased its TriSalus Life Sciences (TLSI) stake by 75% in Q2 2026, buying an estimated $109K and bringing the position to 63,898 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #3513.

Nuveen first reported a position in TLSI in Q2 2025 and has held it in 5 quarters since. 78 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Nuveen held 63,898 shares of TriSalus Life Sciences worth $291K as of Q2 2026.
  • Nuveen bought 27,348 TriSalus Life Sciences shares in Q2 2026, an estimated $109K.
  • TriSalus Life Sciences made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3513 holding.
  • Nuveen first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 78 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.